Home » Newsletters » BioWorld Science

BioWorld Science

April 29, 2003

View Archived Issues

Targeted Genetics and Cystic Fibrosis Foundation Therapeutics collaborate on tgAAV-CF

NIH offers licenses to new chondropsin V-ATPase inhibitor

Effective back and leg pain alleviation reported with infliximab in sciatica

Donepezil plus conventional neuroleptics effective for psychotic symptoms in AD

Tadalafil confirmed to be effective and well tolerated in patients with erectile dysfunction

A potential new indication described for mycophenolate mofetil

Greater benefits found for sildenafil plus sertraline in premature ejaculation

Antitumor efficacy reported for a novel monoclonal antibody in advanced renal cell carcinoma

Highly potent Pfs inhibitors identified at Quorex as potential broad-spectrum antimicrobials

Testosterone gel restores physiological serum levels of testosterone in hypogonadal men

BMS researchers design novel chemokine CCR3 receptor modulators

SCI-induced bladder hyperreflexia improved by NK2 receptor antagonists

New cathepsin inhibitors with utility in osteoporosis therapy reported by Celera

New CXCR2 antagonists and their use in rheumatoid arthritis and COPD

Zeria researchers present new H+/K+-ATPase inhibitors

Novel 5-HT receptor modulators in early development at Pharmacia

Macrocyclic antibacterial agents prepared and tested at Bayer

Indole-based prostanoid DP receptor antagonists newly discovered at Ono

Merck scientists isolate a novel HIV integrase inhibitor from Cytospora cultures

Another series of alpha2/alpha3-selective GABA-A modulators reported by Merck

Celgene discusses progress during the first quarter

First-quarter highlights at Tularik

Nippon Boehringer Ingelheim and Sankyo intend to comarket Alesion

MedImmune postpones MEDI-507 trials in psoriasis

GenVec and NIAID to develop SARS vaccine

Search for SARS treatment at Medarex and MBL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...